Literature DB >> 8699223

Granulocyte colony-stimulating factor (G-CSF) production by astrocytoma cells and its effect on tumor growth.

T Kikuchi1, S Nakahara, T Abe.   

Abstract

We investigated the expression of granulocyte colony-stimulating factor (G-CSF), G-CSF mRNA, and G-CSF receptor mRNA in astrocytoma cell lines, G-CSF in astrocytoma cyst fluid, and the effect of recombinant G-CSF on the proliferation of astrocytoma cells in vitro and in vivo. We first examined supernatants from astrocytoma cell lines for the presence of G-CSF by ELISA. G-CSF was expressed by 6 of 14 astrocytoma cell lines constitutively, and, was detected after stimulation with tumor necrosis factor-alpha (TNF-alpha) in four of eight cell lines which did not produce G-CSF constitutively. G-CSF mRNA was detected by reverse-transcriptase polymerase chain reaction (RT-PCR) in all cell lines studied, suggesting that astrocytoma cells have the potential to produce G-CSF. We also analyzed the presence of G-CSF by ELISA in five astrocytoma cyst fluids. G-CSF was detected in one case. Although, in vitro study, the growth of glioma cells was not affected by rG-CSF, in a mouse model, the administration of G-CSF significantly shortened the time to tumor appearance and accelerated tumor growth. These data suggest that G-CSF has a stimulatory effect on the proliferation of astrocytoma cells in vivo through the mediation of host factors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699223     DOI: 10.1007/bf00146081

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  21 in total

1.  Potential usefulness of a cultured glioma cell line induced by Rous sarcoma virus in B10.A mouse as an immunotherapy model.

Authors:  K Sakamoto; H Hoshino; Y Kiuchi; G Nakano; Y Nagamachi
Journal:  Jpn J Exp Med       Date:  1989-10

2.  Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin.

Authors:  S Dedhar; L Gaboury; P Galloway; C Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

3.  Monokine modulation of human astroglial cell production of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. I. Effects of IL-1 alpha and IL-beta.

Authors:  D J Tweardy; P L Mott; E W Glazer
Journal:  J Immunol       Date:  1990-03-15       Impact factor: 5.422

4.  Nonhematopoietic tumor cells express functional GM-CSF receptors.

Authors:  G C Baldwin; J C Gasson; S E Kaufman; S G Quan; R E Williams; B R Avalos; A F Gazdar; D W Golde; J F DiPersio
Journal:  Blood       Date:  1989-03       Impact factor: 22.113

5.  Phagocytes as carcinogens: malignant transformation produced by human neutrophils.

Authors:  S A Weitzman; A B Weitberg; E P Clark; T P Stossel
Journal:  Science       Date:  1985-03-08       Impact factor: 47.728

6.  Phase I study of recombinant tumor necrosis factor in cancer patients.

Authors:  M Blick; S A Sherwin; M Rosenblum; J Gutterman
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

7.  Intratumoral LAK cell and interleukin-2 therapy of human gliomas.

Authors:  D Barba; S C Saris; C Holder; S A Rosenberg; E H Oldfield
Journal:  J Neurosurg       Date:  1989-02       Impact factor: 5.115

8.  Granulocyte-macrophage colony-stimulating factor (GM-CSF) production by glioblastoma cells. Despite the presence of inducing signals GM-CSF is not expressed in vivo.

Authors:  K Frei; D Piani; U V Malipiero; E Van Meir; N de Tribolet; A Fontana
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

9.  Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.

Authors:  W H Brooks; M G Netsky; D E Normansell; D A Horwitz
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

10.  Cytological characteristics of human glioma-infiltrating lymphocytes stimulated with recombinant interleukin 2 and an anti-CD3 antibody.

Authors:  T Kikuchi; M Watanabe; T Ohno
Journal:  Jpn J Cancer Res       Date:  1991-03
View more
  6 in total

1.  Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression.

Authors:  M M Mueller; C C Herold-Mende; D Riede; M Lange; H H Steiner; N E Fusenig
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

2.  Expression of granulocyte colony stimulating factor receptor in human colorectal cancer.

Authors:  X Yang; F Liu; Z Xu; C Chen; X Wu; G Li; J Li
Journal:  Postgrad Med J       Date:  2005-05       Impact factor: 2.401

3.  Expression of granulocyte colony-stimulating factor receptor in rectal cancer.

Authors:  Xiao-Dong Yang; Ping Huang; Feng Wang; Ze-Kuan Xu
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

Review 4.  The dark side of granulocyte-colony stimulating factor: a supportive therapy with potential to promote tumour progression.

Authors:  Belinda Yeo; Andrew D Redfern; Kellie A Mouchemore; John A Hamilton; Robin L Anderson
Journal:  Clin Exp Metastasis       Date:  2018-07-02       Impact factor: 5.150

5.  Expression of human granulocyte colony stimulating factor (hG-CSF) in colon adenocarcinoma cell line (Caco-2).

Authors:  Snehasis Jana; Hitesh Patel
Journal:  Biotechnol Lett       Date:  2012-06-20       Impact factor: 2.461

6.  Establishment and characterization of a new lung cancer cell line (MI-4) producing high levels of granulocyte colony stimulating factor.

Authors:  Ryoji Harada; Yoshiki Uemura; Makoto Kobayashi; Adriana Zamecnikova; Hideshi Nakata; Takahiro Taguchi; Mutsuo Furihata; Yuji Otsuki; Hirokuni Taguchi
Journal:  Jpn J Cancer Res       Date:  2002-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.